Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, giving promising enhancements throughout a variety of health-related and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, much more trustworthy different for therapeutic use